Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Statistics
Share Statistics
Aptevo Therapeutics has 1.46M shares outstanding. The number of shares has increased by -64.26% in one year.
| Shares Outstanding | 1.46M |
| Shares Change (YoY) | -64.26% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 15.37% |
| Shares Floating | 1.46M |
| Failed to Deliver (FTD) Shares | 373 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 26.51K, so 1.82% of the outstanding shares have been sold short.
| Short Interest | 26.51K |
| Short % of Shares Out | 1.82% |
| Short % of Float | 1.82% |
| Short Ratio (days to cover) | 0.2 |
Valuation Ratios
The PE ratio is -0.05 and the forward PE ratio is -0.31. Aptevo Therapeutics's PEG ratio is 0.
| PE Ratio | -0.05 |
| Forward PE | -0.31 |
| PS Ratio | 0 |
| Forward PS | 0 |
| PB Ratio | 0.26 |
| P/FCF Ratio | -0.05 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aptevo Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.97.
| Current Ratio | 1.72 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.97 |
| Debt / EBITDA | -0.19 |
| Debt / FCF | -0.19 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-652.16K |
| Employee Count | 37 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -98.86% in the last 52 weeks. The beta is 5.75, so Aptevo Therapeutics's price volatility has been higher than the market average.
| Beta | 5.75 |
| 52-Week Price Change | -98.86% |
| 50-Day Moving Average | 2.82 |
| 200-Day Moving Average | 8.19 |
| Relative Strength Index (RSI) | 32.65 |
| Average Volume (20 Days) | 1.88M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -24.6M |
| Net Income | -24.13M |
| EBITDA | -24.6M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -84.67 |
Balance Sheet
The company has 8.71M in cash and 4.63M in debt, giving a net cash position of 4.08M.
| Cash & Cash Equivalents | 8.71M |
| Total Debt | 4.63M |
| Net Cash | 4.08M |
| Retained Earnings | -247.58M |
| Total Assets | 15.59M |
| Working Capital | 4.45M |
Cash Flow
In the last 12 months, operating cash flow was -23.79M and capital expenditures 0, giving a free cash flow of -23.79M.
| Operating Cash Flow | -23.79M |
| Capital Expenditures | 0 |
| Free Cash Flow | -23.79M |
| FCF Per Share | -83.46 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for APVO is $296, which is 29206.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $296 |
| Price Target Difference | 29206.9% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Dec 4, 2024. It was a backward split with a ratio of 1:37.
| Last Split Date | Dec 4, 2024 |
| Split Type | backward |
| Split Ratio | 1:37 |
Scores
| Altman Z-Score | -26.98 |
| Piotroski F-Score | 2 |